Sichuan Huiyu Pharmaceutical Co Ltd
SSE:688553
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Morris Home Holdings Ltd
HKEX:1575
|
CN |
Sichuan Huiyu Pharmaceutical Co Ltd
Research & Development
Sichuan Huiyu Pharmaceutical Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sichuan Huiyu Pharmaceutical Co Ltd
SSE:688553
|
Research & Development
-¥281.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Research & Development
-¥3.4B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Research & Development
-¥6.7B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-22%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Research & Development
-¥323.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Research & Development
-¥1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-18%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Research & Development
-¥1.4B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Sichuan Huiyu Pharmaceutical Co Ltd
Glance View
Sichuan Huiyu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company is headquartered in Neijiang, Sichuan and currently employs 1,480 full-time employees. The company went IPO on 2021-10-26. The Company’s products are mainly anti-tumor chemical injections, including pemetrexed disodium for injection, docetaxel injection, zoledronic acid injection, irinotecan hydrochloride injection, doxorubicin hydrochloride injection liquid and azacitidine for injection. The firm's products are mainly used in the clinical treatment of various adaptive diseases. The firm distributes its products both in the domestic market and to overseas markets.
See Also
What is Sichuan Huiyu Pharmaceutical Co Ltd's Research & Development?
Research & Development
-281.6m
CNY
Based on the financial report for Dec 31, 2024, Sichuan Huiyu Pharmaceutical Co Ltd's Research & Development amounts to -281.6m CNY.
What is Sichuan Huiyu Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-40%
Over the last year, the Research & Development growth was 11%. The average annual Research & Development growth rates for Sichuan Huiyu Pharmaceutical Co Ltd have been -7% over the past three years , -40% over the past five years .
